Literature DB >> 28370893

MicroRNA: an important regulator in acute myeloid leukemia.

Xiaman Wang1, Hongli Chen1, Ju Bai1, Aili He1,2.   

Abstract

MicroRNAs (miRNAs) are a general class of endogenous non-coding RNAs with a length of 22 nucleotides, widely existing in diverse species and playing important roles in malignancies initiation and progression. MiRNAs are essential to many in vivo biological processes such as cell proliferation, apoptosis, immune response, and tumorigenesis. Significant progress till date has been made in understanding the roles of microRNAs in normal hematopoiesis and hematopoietic malignant diseases. In this review, we summarize the particular signatures of microRNAs in acute myeloid leukemia (AML) patients with specific karyotype and the clinical significance of microRNAs in early diagnosis and treatment. MicroRNAs hypermethylation was also proved to correlate with the pathogenesis of AML. However, the target genes and exact pathways of microRNAs participating in these processes are still unknown and more efforts need to be made in the near future.
© 2017 International Federation for Cell Biology.

Entities:  

Keywords:  AML; hypermethylation; leukemogenesis; microRNA; ncRNA; target genes

Mesh:

Substances:

Year:  2017        PMID: 28370893     DOI: 10.1002/cbin.10770

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  13 in total

Review 1.  MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.

Authors:  Stefania Trino; Daniela Lamorte; Antonella Caivano; Ilaria Laurenzana; Daniela Tagliaferri; Geppino Falco; Luigi Del Vecchio; Pellegrino Musto; Luciana De Luca
Journal:  Int J Mol Sci       Date:  2018-02-03       Impact factor: 5.923

2.  A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.

Authors:  Laixi Bi; Bin Zhou; Haiying Li; Licai He; Chunjing Wang; Zhonggai Wang; Liqing Zhu; Mengqian Chen; Shenmeng Gao
Journal:  BMC Cancer       Date:  2018-02-13       Impact factor: 4.430

3.  Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.

Authors:  Chris Lauber; Nádia Correia; Andreas Trumpp; Michael A Rieger; Anna Dolnik; Lars Bullinger; Ingo Roeder; Michael Seifert
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

4.  Differential expression of miRNAs in acute myeloid leukemia quantified by Nextgen sequencing of whole blood samples.

Authors:  Aakriti Pandita; Poornima Ramadas; Aarati Poudel; Nibal Saad; Ankit Anand; Alina Basnet; Dongliang Wang; Frank Middleton; Diana M Gilligan
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

5.  Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.

Authors:  Yingmeng Guo
Journal:  Bioengineered       Date:  2019-12       Impact factor: 3.269

Review 6.  MicroRNAs play an essential role in autophagy regulation in various disease phenotypes.

Authors:  Yunyi Zhao; Ze Wang; Wenhui Zhang; Linbo Zhang
Journal:  Biofactors       Date:  2019-08-16       Impact factor: 6.113

7.  Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin.

Authors:  Huimin Liu; Min Liu; Jiangzhao Zhang; Yan Liang
Journal:  Mol Med Rep       Date:  2020-07-28       Impact factor: 2.952

8.  miR-375 down-regulation of the rearranged L-myc fusion and hypoxia-induced gene domain protein 1A genes and effects on Sertoli cell proliferation.

Authors:  Jia Guo; Xin Liu; Yuwei Yang; Mengdi Liang; Chunyan Bai; Zhihui Zhao; Boxing Sun
Journal:  Asian-Australas J Anim Sci       Date:  2018-03-02       Impact factor: 2.509

9.  Long non-coding RNA LINC01018 inhibits the progression of acute myeloid leukemia by targeting miR-499a-5p to regulate PDCD4.

Authors:  Hong Zhou; Pengfei Shi; Xiaofeng Jia; Qianfu Xue
Journal:  Oncol Lett       Date:  2021-05-20       Impact factor: 2.967

10.  Expression Profiles of Long Non-Coding RNA GAS5 and MicroRNA-222 in Younger AML Patients.

Authors:  Djordje Pavlovic; Natasa Tosic; Branka Zukic; Zlatko Pravdic; Nada Suvajdzic Vukovic; Sonja Pavlovic; Vladimir Gasic
Journal:  Diagnostics (Basel)       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.